Tag: Recipharm

Recipharm Considers to Finish Operations in its UK Facility

The operation has not been profitable for several years; no likely prospect of it being able to deliver an acceptable return in the medium term. Recipharm will initiate a process to explore the dis...

Swedish Alliance for ADHD Treatment

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treat...

Recipharm released the first EU FMD compliant products to Europe

drug-serialization
Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

Recipharm receives EMVO approval

recipharm
Recipharm, a leading contract development and manufacturing organisation has received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

Recipharm starts its standalone serialisation service

recipharm
Recipharm, a leading contract development and manufacturing organisation (CDMO) has announced the launch of its standalone serialisation service ahead of the introduction of the EU Falsified Medicines Directive (FMD).

Recipharm buys Sanofi CMO business in UK

recipharm
Recipharm, a Swedish pharmaceutical contract development and manufacturing organisation (CDMO), made a deal with Sanofi to buy its contract inhalation drug business and plant in the UK.

Recipharm enhances its facility in France with a new manufacturing equipment

pharma
Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at its facility in Kaysersberg, France.

Recipharm launched new GMP suite for manufacture of clinical trial material

clinical-trial-material
Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material